| Literature DB >> 26913242 |
Cheryl L Sershen1, Steven J Plimpton2, Elebeoba E May1.
Abstract
Mycobacterium tuberculosis associated granuloma formation can be viewed as a structural immune response that can contain and halt the spread of the pathogen. In several mammalian hosts, including non-human primates, Mtb granulomas are often hypoxic, although this has not been observed in wild type murine infection models. While a presumed consequence, the structural contribution of the granuloma to oxygen limitation and the concomitant impact on Mtb metabolic viability and persistence remains to be fully explored. We develop a multiscale computational model to test to what extent in vivo Mtb granulomas become hypoxic, and investigate the effects of hypoxia on host immune response efficacy and mycobacterial persistence. Our study integrates a physiological model of oxygen dynamics in the extracellular space of alveolar tissue, an agent-based model of cellular immune response, and a systems biology-based model of Mtb metabolic dynamics. Our theoretical studies suggest that the dynamics of granuloma organization mediates oxygen availability and illustrates the immunological contribution of this structural host response to infection outcome. Furthermore, our integrated model demonstrates the link between structural immune response and mechanistic drivers influencing Mtbs adaptation to its changing microenvironment and the qualitative infection outcome scenarios of clearance, containment, dissemination, and a newly observed theoretical outcome of transient containment. We observed hypoxic regions in the containment granuloma similar in size to granulomas found in mammalian in vivo models of Mtb infection. In the case of the containment outcome, our model uniquely demonstrates that immune response mediated hypoxic conditions help foster the shift down of bacteria through two stages of adaptation similar to the in vitro non-replicating persistence (NRP) observed in the Wayne model of Mtb dormancy. The adaptation in part contributes to the ability of Mtb to remain dormant for years after initial infection.Entities:
Keywords: Mycobacterium tuberculosis; agent based model; dormancy; granuloma; host-pathogen interactions; lung diseases; multiscale modeling; systems biology
Mesh:
Substances:
Year: 2016 PMID: 26913242 PMCID: PMC4753379 DOI: 10.3389/fcimb.2016.00006
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Figure 1Implementation schema for the integrated multiscale model of .
Oxygen parameters used in the integrated multiscale ABM.
| Pulmonary blood volume (pulmonary.blood.source) | 322 | 172 | 634 | ml/ | Uniform | Dock et al., |
| Residual volume of air in lung (residual.volume) | 1.697 | 1.0 | 2.75 | Liters | Uniform | Nagelhout and Plaus, |
| Khurana, | ||||||
| Bartlett, | ||||||
| Diffusion coefficient (in lung tissue—oxygen.difusion.coefficient) | 3.08E−05 | 1.10E−04 | 4.00E−06 | Uniform | MacDougall and McCabe, | |
| Altman and Dittmer, | ||||||
| Hou et al., | ||||||
| Maximum specific growth rate of extracellular | 0.006 | 0.00095 | 0.06 | Hourly | Uniform | Wayne and Hayes, |
| Maximum specific death rate of | 0.0008 | 0.0001 | 0.0009 | Hourly | Uniform | Wayne and Hayes, |
| Maximum specific growth rate of intracellular | 0.012 | 0.0019 | 0.12 | Hourly | Uniform | Ray et al., |
| Half velocity constant (K | 0.4227 | Not varied | ng/ml | Wayne and Hayes, | ||
| Consumption by resting macrophage (mr - resting.mac) | 1.15 | 0.87 | 1.43 | Micromoles/107 cells/hr | Uniform | Conkling et al., |
| Consumption by activated macrophage (ma) | 2.30 | 1.74 | 2.86 | Micromoles/107 cells/hr | Uniform | Loose, |
| Consumption by infected macrophage (mi) | 3.45 | 2.62 | 4.28 | Micromoles/107 cells/hr | Uniform | Loose, |
| Consumption by chronically infected macrophage (mc) | 4.60 | 3.49 | 5.71 | Micromoles/107 cells/hr | Uniform | Loose, |
| Consumption by T cells | 0.14375 | 0.10875 | 0.17875 | Micromoles/107 cells/hr | Uniform | |
| Consumption by | 20.80 | 10.00 | 35.00 | Uniform | Grieg and Hoogerheide, | |
| Alveolar surface area | 130 | 118 | 142 | Not varied | Weibel, |
The oxygen parameters used to add the oxygen field to the ABM.
Estimated from data concerning murine malaria.
Estimated from data collected for E. coli.
Summary of the Python modules developed for the multiscale simulator.
| Simulator | simulator.py | Establish grid and neighborhood stencils; perform integrity checks |
| Particles | particle.py | Create new particles; initialize particles on grid |
| Macrophages: | resting.py | Phacytose bacteria or become infected; remove dead particles from grid (natural death or TNF-induced apoptosis) |
| activated.py | Emit chemokine and cytokine; phagocytose bacteria; remove dead cells from grid (natural death or TNF-induced apoptosis) | |
| infected.py | Emit chemokine and cytokine; intracellular bacteria replication; remove dead particles for grid; may be activated by T cells | |
| chronic.py | Emit chemokine and cytokine; intracellular bacteria replication; bursts if max bacterial load reached; remove dead cells | |
| biasmove.py | Create particle with probability p in vascular source site if chemokine value is above threshold | |
| recruit.py | Remove dead T cells from grid | |
| T cells: | Treg.py | regulates T-γ cell's ability to activate macrophages |
| Tgamma.py | Probability of apoptosis on infected or chronically infected macrophage | |
| Tcytotoxic.py | Chance of perforin/granulysin-mediated killing of infected and chronically infected macrophages | |
| biasmove.py | If within threshold for at least one chemokine, make biased move in the direction of the highest concentration of chemo agent | |
| recruit.py | Create particle with probability p in vascular source site if chemokine value is above threshold | |
| death.py | Remove dead T cells from grid | |
| Fields: | growth.py | Grow extracellular bacteria according to the Monod equation |
| solve.py | Calculate the steady-state solution (Av = f) for the oxygen field via Octave routines | |
| gene expression.py | Calculate gene expression for the component genes and run BioXyce | |
| source.py | Add chemokine and cytokine (TNF/CCL2/CCL5/CXCL9) to chemotactic fields | |
| update.py | Run finite-difference diffusion routine | |
| apoptotic phagocytosis | Dictate macrophage behavior under hypoxia | |
| Stats | stats.py | Time series report on key infection variables |
| Image | dump.py | Create images for animations |
Reactions included in the .
| Citrate synthase (CS) | 1 OA + 1 ACCOA = 1 CIT + 1 COA | Rv0896 OR Rv0889c OR Rv1131 |
| Aconitase (ACN) | 1 CIT = 1 ICIT | Rv1475c |
| Isocitrate dehydrogenase 1 (ICD1) | 1 ICIT = 1 AKG | Rv3339c OR Rv0066c |
| Isocitrate dehydrogenase 2 (ICD2) | 1 ICIT = 1 AKG | Rv3339c OR Rv0066c |
| Alpha-ketoglutarate decarboxylase (KGD) | 1 AKG = 1 SUCCSAL | Rv1248c OR Rv0555 |
| Succinic semialdehyde dehydrogenase (SSADH) | 1 SUCCSAL = 1 SUCC | Rv0234c OR Rv1731 |
| Succinate dehydrogenase (SDH) | 1 SUCC + 1 FAD = 1 FUM + 1 FADH2 | Rv3318 AND Rv3319 AND Rv3316 AND Rv3317 |
| Fumarase (FUM) | 1 FUM = 1 MAL | Rv1098c |
| Malate dehydrogenase (MDH) | 1 MAL + 1 NAD = 1 OA + 1 NADH | Rv1240 |
| Isocitrate lyase 1 (ICL1) | 1ICIT = 1GLX+1SUCC | Rv0467 OR (Rv1915 AND Rv1916) |
| Isocitrate lyase 2 (ICL2) | 1ICIT = 1GLX+1SUCC | Rv0467 OR (Rv1915 AND Rv1916) |
| Malate synthase (MS) | 1 GLX + 1 ACCOA = 1 MAL + 1 COA | Rv1837c |
| Alanine dehydrogenase/glycine dehydrogenase (GDH/ALD) | 1 GLX + 1 NADH = 1 GLY + 1 NAD | Rv2780 OR GDH |
| NADH dehydrogenase (NUO) | NADH + 0.5 O2 = NAD + 2H | Rv3145 AND Rv3146 AND Rv3147 AND Rv3148 AND Rv3149 AND |
| Rv3150 AND Rv3151 AND Rv3152 AND Rv3153 AND Rv3154 | ||
| AND Rv3155 AND Rv3156 AND Rv3157 AND Rv3158 | ||
| NADH reductase (Non-proton translocating, NDH) | 1 NADH + 0.5 O2 = 1 NAD | Rv1854c OR Rv0392c |
| Succinate dehydrogenase (SDH) | FADH2 + 0.5 O2 = FAD + 2H | (Rv3318 AND Rv3319 AND Rv3316 AND Rv3317) OR |
| (Rv1552 AND Rv1553 AND Rv1554 AND Rv1555) | ||
| ATP Synthase (ATPase) | 1 ADP + 1 PI + 4 H = 1 ATP | Rv1308 AND Rv1304 AND Rv1311 AND Rv1310 AND Rv1305 |
| AND Rv1306 AND Rv1309 AND Rv1307 |
Explanation of simulation data sets used to generate figures of aggregate results and comparative outcome for ABM-PHYS and ABM-ST.
| Variable parameter | Comparison of average phenotypes across | Supplementary Figures | |
| all outcome categories (clearance, containment, dissemination). | |||
| Comparison of statistical distribution of outcomes | Figure | ||
| for | |||
| Identification of statistically significant model | Supplementary Figure | ||
| parameters across all outcomes. | |||
| Identification of statistically significant model | Supplementary Figure | ||
| parameters for containment and dissemination outcomes. | |||
| Fixed parameter | Outcome specific comparison of bacterial load phenotype. | Figure | |
| Comparative analysis of the hypoxic region of | Figure | ||
| containment granulomas. | |||
| Comparison of the bacterial load in | Figure | ||
| vs. | |||
| Comparison of | Supplementary Figure | ||
| and dissemination outcomes. |
Aggregate or average results are generated based on the N = 300 LHS simulation run set or from fixed parameter simulation sets (parameters used for fixed parameter studies are listed in Appendix 4 in Supplementary Material). Figure 6, Supplementary Figures 3–5, 6A are generated using the N = 300 simulation set for both the standard and integrated ABM models, where we categorized outcomes as described in Appendix 1 in Supplementary Material. Supplementary Figure 6B is produced using 41 of 150 simulation results (over the same parameter space as the N = 300 simulation set) in order to investigate which significant parameters result when we exclude the clearance outcomes. Figure 5, which compares the number of extracellular bacteria in the standard ABM to the integrated ABM, is generated from 5 to 6 fixed parameter simulations for each scenario. In the remaining figures we used fixed parameter simulation runs to generate a sufficient number of containment samples for comparative analysis and characterization of the containment response: Figure 7 results are based on 20 simulations representing 6 solid containment granulomas and 14 caseous containment granulomas (of the 20 simulations, 4 were from the N = 300 sample run set and 16 from fixed parameter simulation runs); Figure 9 results are based on 10 fixed parameter simulations for the standard ABM and 22 simulations for the integrated multiscale ABM (of the 22 simulations, 1 was from the N = 300 sample run and 21 from fixed parameter simulation runs); Supplementary Figure 2 results are based on 20 simulations (10 were from the N = 300 sample run set and 10 from fixed parameter simulation runs).
Figure 2Containment granuloma with TNFα, contains bacteria characterizable as in a state comparable to non-replicating persistence at 500 days. (A) Partial pressure of oxygen across the granuloma (B) oxygen depletion rate (C) bacterial growth rates for extracellular (D) and intracellular (E) bacteria; scaled NAD/NADH ratio for both extracellular (F) and intracellular (G) bacteria; change in ATP concentration for extracellular (H) and intracellular (I) bacteria.
Figure 3Comparison of transient containment outcomes at 67 days post infection (A,B) and 200 days post infection; the standard re-implemented model (ABM-ST) results in dissemination (C) and the physiologically-based model (ABM-PHYS) results in a loosely packed containment (D). True containment outcomes shown at 200 days post-infection (both ABM models result in containment E,F). Simulation models use the same parameters for ABM-ST (left) and ABM-PHYS (right). See Appendix 4 in Supplementary Material for relevant parameters.
Figure 4Comparison of dissemination outcomes in the absence of TNF-α for ABM-ST (A) and ABM-PHYS (B). See Appendix 4 in Supplementary Material for relevant parameters.
Figure 5Comparison of extracellular bacterial load of ABM-ST vs. ABM-PHYS model for each of the three scenarios in Figure . Results represent an average of six simulations in all scenarios except the transient containment scenario for ABM-ST, which has five simulations. Bacterial loads for containment in the integrated model mimic trajectories reported from in vivo studies (Lin et al., 2014).
Figure 6Comparison of . Comparison of Gideon et al. (2015) experimental data (blue) and the ABM-PHYS model with oxygen dynamics (red): relative distribution of each qualitative outcome—clearance, containment and dissemination (A) distribution of lesions based on bacterial load (B) comparison of ABM-ST (blue) and the ABM-PHYS model (red) based on the distribution of qualitative outcomes (C) distribution across qualitative outcomes for 1,2, and 3 loci models of the ABM-PHYS model (D). In silico outcomes based on multisample averages of 300 total simulations.
Figure 7For the containment granuloma: average area of the hypoxic region in . Containment granulomas were divided into two groups: caseous and solid. NRP stages (Wayne and Hayes, 1996) are notated (right). Results based on 20 simulation runs.
Figure 8Dissemination and the corresponding oxygen field at 54, 181, and 200 days post-infection. Severe hypoxia is seen on day 181, which resolves by day 200.
Figure 9Total CFU for . In silico results are based on 10 simulations for ABM-ST and 22 simulations for ABM-PHYS.
Containment and dissemination parameters for simulation runs used in sensitivity analysis.
| Probability a resting macrophage kills a bacterium in his compartment | Per 10 minutes | 0.0541 | 0.0131 | 0.0972 | 0.0486 | 0.0162 | 0.0781 |
| Probability a macrophage is recruited from a vascular source | Per 10 minutes | 0.0661 | 0.0213 | 0.1405 | 0.0631 | 0.0188 | 0.1294 |
| Probability a T cell is recruited at a vascular source | Per 10 minutes | 0.0542 | 0.011 | 0.137 | 0.109 | 0.0754 | 0.1415 |
| Proportion of T cells recruited that are regulator T cells | Per 10 minutes | 0.0763 | 0.0125 | 0.1562 | 0.152 | 0.0208 | 0.196 |
| Chemokine diffusion constant | cm2/per second | 6.00E-08 | 1.86E-08 | 1.07E-07 | 7.89E-08 | 3.29E-08 | 1.05E-07 |
| Chemokine halflife | Hours | 1.45 | 0.64 | 2.24 | 1.49 | 0.77 | 2.27 |
| CCL5 secretion | No. molecules secreted hourly | 2.78E+05 | 7.53E+04 | 4.59E+05 | 2.60E+05 | 6.34E+04 | 4.37E+05 |
| TNF diffusion constant | cm2/per second | 4.31E-08 | 1.99E-08 | 1.01E-07 | 7.87E-08 | 2.56E-08 | 1.12E-07 |
| TNF halflife | Hours | 7.12 | 1.19 | 11.17 | 5.22 | 2.31 | 8.42 |
| Probability a macrophage undergoes apoptosis | Per 10 minutes | 0.13 | 0.08 | 0.19 | 0.1 | 0.04 | 0.18 |
| Threshold required for macrophage recruitment | Checked every ten minutes | 6.96E+05 | 1.97E+05 | 1.44E+06 | 1.08E+06 | 8.27E+05 | 1.45E+06 |
| Oxygen in lung tissue due to pulmonary blood volume | Steady-state number of molecules | 5.68E+08 | 2.81E+08 | 9.42E+08 | 5.76E+08 | 3.43E+08 | 8.39E+08 |
| Oxygen in lung tissue due to residual volume in lung | Steady-state number of molecules | 9.53E+08 | 4.02E+08 | 1.35E+09 | 8.61E+08 | 6.09E+08 | 1.09E+09 |
| Oxygen consumption by a resting macrophage | Number of molecules per 1 breath | 7.19E+07 | 6.16E+07 | 8.15E+07 | 7.55E+07 | 5.88E+07 | 9.46E+07 |
| Oxygen consumption by bacteria | Number of molecules per 1 breath | 8.77E+05 | 5.50E+05 | 1.15E+06 | 8.07E+05 | 4.90E+05 | 9.98E+05 |
| Oxygen diffusion coefficient | cm2/per second | 5.83E-05 | 5.98E-06 | 1.10E-04 | 5.03E-05 | 5.38E-06 | 8.82E-05 |
| TNF threshold necessary to activate a macrophage | Checked every 10 min | 1.82E+05 | 6.68E+03 | 3.18E+05 | 2.02E+05 | 4.09E+04 | 3.44E+05 |
| Probability an infected macrophage becomes activated | Per 10 minutes | 2.92E-02 | 3.37E-04 | 7.52E-02 | 3.05E-03 | 3.14E-04 | 8.91E-03 |
| Probability a T cell moves into a compartment occupied by a macrophage | Per 10 minutes | 1.65E-03 | 1.90E-05 | 8.18E-03 | 2.91E-02 | 1.03E-05 | 8.88E-02 |
| TNF/chemokine threshold for T cell recruitment at a vascular source | Checked every 10 min | 1.73E+04 | 1.17E+03 | 8.13E+04 | 7.73E+03 | 2.64E+03 | 1.55E+04 |
| TNF/chemokine threshold for macrophage recruitment at a vascular source | Checked every 10 min | 1.32E+04 | 1.24E+03 | 8.76E+04 | 7.19E+03 | 1.39E+03 | 2.30E+04 |
| Lower threshold for recruitment of CCL5 | Checked every 10 min | 3.09E+05 | 1.75E+04 | 7.18E+05 | 1.28E+05 | 1.69E+04 | 4.40E+05 |
| Upper threshold for recruitment of CCL5 | Checked every 10 min | 1.83E+05 | 1.22E+04 | 6.79E+05 | 3.68E+04 | 1.58E+04 | 6.60E+04 |
| TNF secretion | No. molecules per 10 min | 5.33E+06 | 9.50E+04 | 2.87E+07 | 3.82E+06 | 2.09E+04 | 1.67E+07 |
| Effect of TNF on resting macrophage recruitment | Checked every 10 min | 225.53 | 12 | 706.96 | 255 | 16.39 | 875.23 |
| Maximum specific growth rate | Hourly | 0.0127 | 0.0024 | 0.0386 | 0.0343 | 0.0305 | 0.0379 |
| Maximum specific death rate | Hourly | 0.0004 | 0.0001 | 0.0008 | 0.0006 | 0.0004 | 0.0007 |
Model parameters used for the standard and integrated ABM.
| Intracellular | 0.002 | 0.0002 | 0.002 | Per 10 min | Uniform | |
| Extracellular | 116 | 20 | 200 | Hours | Log-Uniform | Ray et al. ( |
| Initial number of macrophages | 105 | Not varied | ||||
| Probability of Mr killing bacteria (pK) | 0.015 | 0.01 | 0.1 | Per 10 min | Uniform | |
| Probability of Mi activation by T cell (prob.actm) | 0.05 | 0.0001 | 0.1 | Per 10 min | Log-Uniform | |
| Probability of macrophage recruitment (prob. recruit.mac) | 0.05 | 0.01 | 0.1 | Per 10 min | Uniform | |
| Probability of T cell recruitment | 0.075 | 0.01 | 0.1 | Per 10 min | Uniform | |
| Probability of T-γ cell | 0.555 | 0.594 | 0.54 | Per 10 min | Uniform | |
| Probability of cytotoxic T cell | 0.2775 | 0.297 | 0.27 | Per 10 min | Uniform | |
| Probability of a T cell moving onto an occupied compartment (Tmove) | 0.01 | 0.00001 | 0.1 | Per 10 min | Log-Uniform | |
| Proportion of Treg cells out of all T cells recruited (T.prob.recruit.reg) | 0.1 | 0.01 | 0.2 | Per 10 min | Uniform | |
| Chemokine diffusion rate (chemokine.diffusion.constant) | 1.05E−07 | 1.67E−08 | 1.17E−07 | Uniform | ||
| Chemokine half-life (chemokine.halflife) | 7.38E−01 | 6.0E−01 | 2.3E−00 | Hours | Uniform | |
| Combined TNF/chemokine threshold for T cell recruitment at a vascular source (r.T) | 1.00E+03 | 1.00E+03 | 1.00E+05 | Molecules | Log-Uniform | |
| Combined TNF/chemokine threshold for Mr recruitment at a vascular source | 1.00E+03 | 1.00E+03 | 1.00E+05 | Molecules | Log-Uniform | |
| CCL5 production rate | 4.50E+05 | 6.00E+04 | 6.00E+05 | Hours | Uniform | |
| Macrophage CCL5 saturation threshold (CCL5uthresh) | 1.41E+04 | 1.00E+04 | 1.00E+06 | Molecules | Log-Uniform | |
| Macrophage CCL5 threshold | 2.00E+04 | 1.00E+04 | 1.00E+06 | Molecules | Log-Uniform | |
| TNF diffusion rate | 1.09E−07 | 1.67E−08 | 1.17E−07 | Uniform | ||
| TNF half-life | 3.6E−01 | 3.6E+01 | 11.55E+00 | Hours | Uniform | |
| TNF production rate | 4.65E+06 | 6.00E+04 | 3.00E+07 | Molecules Per hour | Log-Uniform | Marion et al. ( |
| Probability of TNF-induced apoptosis (p.apopt) | 0.100 | 0.001 | 0.200 | Per 10 min | Uniform | |
| Macrophage TNF detection threshold | 7.00E+05 | 1.00E+05 | 1.50E+06 | Molecules | Uniform | |
| Threshold Effect of TNF on Mr recruitment (tao.TNF.actm) | 150 | 10 | 1000 | Molecules | Log-Uniform | |
| Carrying capacity for | 220 | Not varied | ||||
| Macrophage lifetime | 100 | Not varied | Days | |||
| T cell lifetime | 3 | Not varied | Days | |||
| Maximum number of bacteria killed by resting macrophage | 2 | Not varied | ||||
| Percent of internal bacteria being destroyed by killing | 0.50 | Not varied | ||||
| No. of bacteria killed by activated macrophage | 10 | Not varied | ||||
| Length of time T-reg incapacitates T-γ | 110 | Not varied | Minutes | |||
| Probability of cytotoxic T cell killing | 0.75 | Not varied | ||||
| Probability cytotoxic T cells kills mc with bacterial release | 0.20 | Not varied |
Parameters are the same as those used in Ray et al. (2009) unless otherwise stated.
Significant Partial Rank Correlation Coefficients for the integrated multiscale model of oxygen-modulated host response to .
| Chemokine diffusion constant | – | Fast diffusion of chemokine can lead to an increased rate of signaling to neighboring cells, positively |
| affecting macrophage recruitment toward the site of infection and leading to lower levels | ||
| of extracellular bacteria (EB). | ||
| Pulmonary blood source | + | More pulmonary blood provides increased oxygen to the lung thus higher EB level can persist. |
| Residual volume | + | Higher residual volume provides more oxygen to tissues, thus is a more friendly environment for EB. |
| Macrophage O2 consumption | – | Higher oxygen consumption by macrophages leaves less oxygen available for bacteria, |
| thus is negatively correlated to EB. | ||
| O2 bacterial consumption | – | High consumption by a single bacterium leaves less O2 available for other bacteria. |
| Oxygen diffusion coefficient | + | The faster oxygen diffuses through tissues, the more oxygen is readily available to EB. |
| Tmove | – | Enables a more tightly controlled granuloma facilitating activation of macrophages, therefore lower EB. |
| CCL5uthreshold | + | Higher threshold implies less recruiting of macrophages at vascular source sites, so more EB may persist. |
| mu max | + | Higher growth rate of EB has positive impact on EB levels. |
Positive correlations with extracellular bacteria level:(+) = p ≤ 0.025;(++) = p ≤ 0.01;(+++) = p ≤ 0.001;Negative correlations with EBL:(−) = p ≤ 0.025;(–) = p ≤ 0.01.